Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix

Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix

Channel NewsAsia - Asia·2020-06-19 17:14

BEIJING: A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday (Jun 19) an early-stage study of its candidate was underway with vaccine boosters from the United Kingdom's GSK and United States-based Dynavax.

……

Read full article on Channel NewsAsia - Asia

Health News SE Asia

Comments

Leave a comment in Nestia App